GLP-1 weight-loss drugs may lower the need for knee replacement

GLP-1 drugs, such as semaglutide and tirzepatide, used for diabetes and weight loss, may also reduce knee osteoarthritis pain and delay knee replacement surgery. In a large 2026 study, the use of any GLP-1 was linked to a reduced likelihood of knee replacement over eight years.